Apple can no longer sell its newest smartwatches, the Apple Watch Series 9 and Watch Ultra 2, in the U.S. after President Biden declined to veto a product ban implemented by the International Trade Commission (ITC) that cited patent infringement.
The ban, which came into effect this week, was implemented by the ITC in October to protect medtech company Masimo, which sued Apple in 2020 for...
A smartwatch trade secrets battle between Apple and health tech company Masimo ended in a mistrial yesterday when jurors failed to reach an unanimous verdict.
Masimo sued Apple in 2020 for allegedly poaching its employees and stealing trade secrets related to technology that uses light to measure blood oxygen levels in the Apple Watch. The company had been seeking more than $1.8 billion in...
Medtech company Masimo announced it had received FDA De Novo clearance for Opioid Halo, the company's opioid overdose alert system.
The monitoring system aims to prevent overdose by alerting family members or caregivers when a patient is experiencing opioid-induced respiratory depression, or slowed or stopped breathing that can be fatal.
Opioid Halo includes four components: a fingertip sensor, a...
Medtech companies Philips and Masimo are expanding their patient monitoring partnership to include the latter's new W1 wearable.
The collaboration allows vital sign data from the W1 watch to be sent to Philips' patient monitoring ecosystem, so clinicians can keep an eye on patients after they've been discharged from the hospital.
Masimo launched the W1 for consumer use in August. At the time,...
Medical device company Masimo has accused Apple of patent infringement, filing a complaint against the company with the U.S. International Trade Commission yesterday.
Bloomberg, which first spotted the news, reports that the accusations are specifically against Apple's Series 6 smartwatch blood oxygenation tool, which uses light transmitted throughout the body to gauge blood oxygen levels.
In...
Medical device maker Masimo is the latest company to develop a solution to help businesses, schools and other organizations reopen. Today, it announced the release of SafetyNet-OPEN, a web and mobile app solution that can screen, trace and manage users as they return to work.
The back-to-work tool builds upon Masimo's SafetyNet remote monitoring system that was developed at the beginning of the...
Medtech company Masimo announced today that it is launching the Radius T Continuous Thermometer, a connected sensor system that can take a patient’s temperature over time in lieu of the manual process, for consumers.
The tool is able to send temperature readings and also warning alerts if there is a spike to a corresponding app. Users can customize the alerts and notifications functions. The app...
Medical device creator Masimo announced today its latest 510(k) clearance from the U.S. Food and Drug Administration for the Rad-G pulse oximeter.
The Rad-G is a handheld device that combines Masimo’s signal extraction technology (SET) pulse oximetry and respiration rate from the pleth (RRp) that can be used to spot-check or continually monitor.
It’s lightweight, handheld, and has a 24-hour...
Capsule Technologies, a medical device-maker (not to be confused with digital pharmacy Capsule), has just landed FDA 510(k) clearance for its new connected capnography-monitoring technology.
Called Vitals Plus monitoring solution, it was created to incorporate Masimo's NomoLine ISA CO2, and designed to keep track of a patient's end-tidal carbon dioxide, respiratory rate, and fractional inspired...
Connected care company Masimo has landed and expanded FDA clearance for its O3 Regional Oximeter, for both somatic applications and monitoring changes in the cerebral hemoglobin.
It specifically monitors somatic tissue oxygenation saturation, and can detect changes in a patient’s hemoglobin, oxyhemoglobin and deoxyhemoglobin.
According to the company, its tool differs from peripheral pulse...
